Other Events ·
OrthoPediatrics Corp. provides FY2026 revenue guidance of $270M to $273M and adjusted EBITDA of ~$25M
KIDSOrthopediatrics Corp
OrthoPediatrics Corp. furnished an investor presentation outlining its financial outlook for the fiscal year ending in 2026. The company expects total revenue to reach between $270.0 million and $273.0 million, representing 14% to 16% growth compared to prior periods. Management projects adjusted EBITDA of approximately $25.0 million and anticipates free cash flow breakeven for the full year. The guidance assumes total set deployments of roughly $10.0 million. OrthoPediatrics Corp. is a medical device company that develops, manufactures, and markets specialized surgical implants and instruments exclusively for pediatric orthopedic conditions.